Vista, CA ; 04/02/2020
Amount Funded: $25.5 Million
Lead Investor: Vensana Capital, Amgen Ventures
Participating Investor(s): Unnamed investors
Total Funding to Date: $58 Million
Company Description: GPB Scientific is a pioneering biomedical company working with leading research institutes and universities to develop breakthrough technologies to get people better. GPB Scientific’s Curate™ Cell Processing System applies microfluidic deterministic lateral displacement in advanced biocompatible cartridges and an easy to use robust, closed fluid path instrumentation system to consolidate multiple processing steps to reduce processing time and provide enhanced cell recovery gently and without cell damage.
What funding will be used for: Continue development of technologies for cell production, bio-processing.
“We are grateful for the support and confidence that Vensana and Amgen Ventures have placed in GPB Scientific for the continued development and commercialization of our Curate system. Our company was founded with a commitment to apply the groundbreaking microfluidic technology we have developed to get people better, and the strength of this $25.5 million financing will ensure we achieve that goal.”
-Mike Grisham, CEO, GBP Scientific
Data provided by respective company (unless otherwise noted) and researched by StartupsOne for accuracy.